Idiopathic Esophagogastric Junction Outflow Obstruction
Condition(s):Esophagogastric Junction DisorderLast Updated:March 4, 2022Withdrawn
Hide Studies Not Open or Pending
Condition(s):Esophagogastric Junction DisorderLast Updated:March 4, 2022Withdrawn
Condition(s):Esophagogastric Junction DisorderLast Updated:June 24, 2021Unknown status
Condition(s):Gastric Cancer; Esophagogastric Junction DisorderLast Updated:March 30, 2023Recruiting
Condition(s):Esophagogastric Junction Disorder; NeoplasmsLast Updated:December 23, 2019Not yet recruiting
Condition(s):Gastric Cancer; Esophagogastric Junction DisorderLast Updated:April 11, 2019Unknown status
Condition(s):Cancer of Esophagus; Esophagogastric Junction DisorderLast Updated:March 8, 2024Recruiting
Condition(s):Stomach Neoplasm; Gastrointestinal Neoplasms; Digestive System Neoplasm; Esophageal Neoplasms; Head and Neck Neoplasms; Gastrointestinal Disease; Digestive System Disease; Esophageal Diseases; Stomach Diseases; Esophagogastric Junction DisorderLast Updated:February 7, 2024Completed
Condition(s):Stomach Neoplasms; Esophagogastric Junction Disorder; Neoadjuvant Therapy; Chemoradiotherapy; Immunotherapy; Gastrectomy; Adenocarcinoma; Adjuvant TherapyLast Updated:December 17, 2021Recruiting
Condition(s):Gastroesophageal Reflux DiseaseLast Updated:July 22, 2022Recruiting
Condition(s):Carcinoma; Gastrointestinal Diseases; Stomach Cancer; Gastroesophageal-junction Cancer; Digestive System Diseases; Gastric Cancer; Gastrointestinal NeoplasmsLast Updated:November 7, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.